N@N

Li Watsek Reiterated (ASND) at Buy and Held Target at $173 on, May 15th, 2024

Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $173 on, May 15th, 2024.

Li has made no other calls on ASND in the last 4 months.

There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Vikram Purohit of "Morgan Stanley" Maintained at Hold and Held Target at $116 on, Monday, April 22nd, 2024

These are the ratings of the 4 analyists that currently disagree with Li

---

• Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $262 on, Friday, May 3rd, 2024
• Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $170 on, Friday, May 3rd, 2024
• Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
• David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024

Contributing Sources

---